Global Health Contract

CONSULTANT, DRUG SAFETY PHYSICIAN

Drugs for Neglected Diseases initiative

Posted

Jun 15, 2026

Location

Remote (EU)

Type

Contract

Deadline

⏰ Jul 13, 2026

Mission

What you will drive

  • Review clinical trial documents and lead analysis of safety data (adverse events, lab data, vital signs) to update risk management plans.
  • Lead the Product Safety Management Team, perform signal detection and evaluation, and ensure documentation of safety assessments.
  • Contribute to regulatory reporting (ICSRs, aggregate reports) and collaborate with internal/external committees on safety profile and risk management.
  • Stay updated on global pharmacovigilance regulations, participate in capacity building, and support audits/inspections.

Impact

The difference you'll make

This role directly contributes to the development of safe and effective treatments for neglected diseases, ensuring patient safety and enabling access to new therapies for underserved populations worldwide.

Profile

What makes you a great fit

  • Physician (MD) with 12+ years overall professional experience including 2-5 years of pharmacovigilance experience in industry.
  • Excellent knowledge of clinical development process and ability to manage competing tasks in a fast-paced environment.
  • Proficiency in MS Office, MedDRA, WHOART, and working knowledge of safety databases.
  • Fluent in English; experience with regulatory interactions and neglected disease populations is advantageous.

Benefits

What's in it for you

Part-time (50%) consultancy position with flexible location (Africa, Europe, Latam). Compensation details not specified.

About

Inside Drugs for Neglected Diseases initiative

Visit site →

Drugs for Neglected Diseases initiative (DNDi) is a nonprofit research and development organization that drives therapeutic innovation from lab bench to patient bedside, advancing treatment candidates for neglected diseases.